Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03156322
Other study ID # Inonu Anesthesia
Secondary ID
Status Completed
Phase N/A
First received May 9, 2017
Last updated May 16, 2017
Start date January 1, 2016
Est. completion date January 1, 2017

Study information

Verified date May 2017
Source Inonu University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to compare the effect of different epidural initiation volumes on postoperative pain scores, local anesthetic requirements, and motor block in patients who undergo patient controlled epidural analgesia for postoperative pain after cesarean section.


Description:

90 minutes after combined epidural spinal catheter insertion, three different volumes (5 mL, 10 mL, and 20 mL) are administered with a patient-controlled epidural analgesia (PCEA) device through the epidural catheter. For each group, 0.625% bupivacain + 2 μg/mL fentanyl, is administered.

The visual analog scale, first analgesic demand time, the number of PCEA requirement per hour, morphine requirement, nausea-vomiting, itching, motor block, hypotension, and total consumed analgesic, and ephedrine amounts of the patients are recorded in the recovery room and at postoperative 2, 4, 6, 12 hours.


Recruitment information / eligibility

Status Completed
Enrollment 81
Est. completion date January 1, 2017
Est. primary completion date December 1, 2016
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- American Society of Anesthesiology risks classification II

- Term pregnant

Exclusion Criteria:

- Multiple pregnancy

- Diabetes mellitus

- Hypertension

- Coagulopathy

- Severe cardiac, neurological and pulmonary disease

- Allergy to the study drugs

- Difficulty in understanding the use of the patient controlled analgesia device

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
5 mL epidural initiation volume (bupivacaine + fentanyl)
5 mL 0.625% bupivacaine + 2 µg/mL fentanyl solution is administered from epidural catheter
10 mL epidural initiation volume (bupivacaine + fentanyl)
10 mL 0.625% bupivacaine + 2 µg/mL fentanyl solution is administered from epidural catheter
20 mL epidural initiation volume (bupivacaine + fentanyl)
20 mL 0.625% bupivacaine + + 2 µg/mL fentanyl solution is administered from epidural catheter

Locations

Country Name City State
Turkey Inonu University Turgut Ozal Medical Center Malatya

Sponsors (1)

Lead Sponsor Collaborator
Inonu University

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Sng BL, Woo D, Leong WL, Wang H, Assam PN, Sia AT. Comparison of computer-integrated patient-controlled epidural analgesia with no initial basal infusion versus moderate basal infusion for labor and delivery: A randomized controlled trial. J Anaesthesiol — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Side effects associated with epidural analgesia Nausea-vomiting, itching, motor block, hypotension up to 12 hours after cesarean delivery
Primary Change in postoperative pain scores Visual analog scale up to 12 hours after cesarean delivery
Secondary First analgesic demand time Time to first analgesic requirement (first patient controlled epidural analgesic demand time) up to 12 hours after cesarean delivery
Secondary The number of analgesic requirement The number of patient controlled epidural analgesic requirement per hour up to 12 hours after cesarean delivery
Secondary Morphine requirement Intravenous morphine administration up to 12 hours after cesarean delivery
See also
  Status Clinical Trial Phase
Completed NCT05480111 - The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy Phase 4
Completed NCT06129305 - Erector Spina Muscle Distance From the Skin at Different Thoracal Elevations
Completed NCT04401826 - Micro-surgical Treatment of Gummy Smile N/A
Recruiting NCT04020133 - the Role of Popliteal Plexus Block in Pain Management After Anterior Cruciate Ligament Reconstruction. N/A
Completed NCT03023462 - Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair N/A
Completed NCT03652103 - Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy Phase 4
Completed NCT03546738 - Spinal Cord Burst Stimulation for Chronic Radicular Pain Following Lumbar Spine Surgery N/A
Withdrawn NCT03528343 - Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy Phase 1/Phase 2
Terminated NCT03261193 - ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain Phase 3
Completed NCT02525133 - Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty Phase 3
Completed NCT03244540 - Regional Analgesia After Cesarean Section Phase 4
Enrolling by invitation NCT05316168 - Post Operative Pain Management for ACL Reconstruction Phase 3
Recruiting NCT04130464 - Intraperitoneal Infusion of Analgesic for Postoperative Pain Management Phase 4
Enrolling by invitation NCT04574791 - Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty N/A
Completed NCT04073069 - Scalp Infiltration With Diprospan Plus Ropivacaine for Postoperative Pain After Craniotomy in Adults Phase 4
Completed NCT04526236 - Influence of Aging on Perioperative Methadone Dosing Phase 4
Recruiting NCT05351229 - Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery Phase 4
Enrolling by invitation NCT05543109 - Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block N/A
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04919317 - Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty Phase 2